A detailed history of Humankind Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Humankind Investments LLC holds 29,170 shares of BMY stock, worth $1.51 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
29,170
Previous 27,739 5.16%
Holding current value
$1.51 Million
Previous $1.5 Million 19.48%
% of portfolio
0.33%
Previous 0.4%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $57,597 - $75,828
1,431 Added 5.16%
29,170 $1.21 Million
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $148,402 - $168,259
3,093 Added 12.55%
27,739 $1.5 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $213,457 - $254,713
4,403 Added 21.75%
24,646 $1.26 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $57,368 - $64,147
991 Added 5.15%
20,243 $1.17 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $553,958 - $615,084
-8,695 Reduced 31.11%
19,252 $1.23 Million
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $155,798 - $176,710
2,371 Added 9.27%
27,947 $1.94 Million
Q4 2022

Jan 26, 2023

SELL
$68.48 - $81.09 $51,154 - $60,574
-747 Reduced 2.84%
25,576 $0
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $618 - $365,758
4,760 Added 22.07%
26,323 $1.87 Million
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $45,314 - $49,907
-624 Reduced 2.81%
21,563 $1.66 Million
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $157,142 - $188,428
-2,556 Reduced 10.33%
22,187 $1.62 Million
Q4 2021

Mar 21, 2022

BUY
$53.63 - $62.52 $325,587 - $379,558
6,071 Added 32.51%
24,743 $1.54 Million
Q3 2021

Mar 21, 2022

BUY
$59.17 - $69.31 $85,263 - $99,875
1,441 Added 8.36%
18,672 $1.11 Million
Q2 2021

Mar 21, 2022

BUY
$61.91 - $67.42 $386,504 - $420,903
6,243 Added 56.82%
17,231 $1.15 Million
Q1 2021

Mar 21, 2022

BUY
$59.34 - $66.74 $652,027 - $733,339
10,988 New
10,988 $694,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $110B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.